Jong‐Mu Sun

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Nayoung Kim, Hong Kwan Kim, Kyungjong Lee et al. · Nature Communications · 2020 · 1.3K citations · Full text

Metastatic Lung Adenocarcinoma, Immunology, Cancer Biology +20

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)

Jang Ho Cho, Sung Hee Lim, Ho Jung An et al. · Journal of Clinical Oncology · 2019 · 346 citations · Full text

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial

Jinhyun Cho, Hae Su Kim, Bo Mi Ku et al. · Journal of Clinical Oncology · 2018 · 330 citations · Full text

Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04

Jin Seok Ahn, Yong Chan Ahn, Joo-Hang Kim et al. · Journal of Clinical Oncology · 2015 · 251 citations · Full text

Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial

Se‐Hoon Lee, Jake June-Koo Lee, Myung‐Ju Ahn et al. · Annals of Oncology · 2016 · 248 citations

Pretreated Patients, Medicine, Bronchial Neoplasm +6